Among the 47 patients, 19 cases (40.4%) of CD70 expression levels on AML blast exceeded the response threshold of 1.6 and the remaining patients had low CD70 expression levels and did not support nb70CAR-T treatment. The gene discussed is CD70; the disease is acute myeloid leukemia.